Teva gets FDA nod for polyethylene glycol 3350 NF for oral solution

The US FDA has granted final approval for Teva Pharmaceutical Industries ANDA for polyethylene glycol 3350 NF for oral solution, 17 gram/scoopful. Teva's Polyethylene Glycol 3350 NF for oral solution is the AB-rated generic equivalent of Braintree's Miralax for oral solution, a product indicated for the treatment of occasional constipation. Total annual sales of Polyethylene Glycol 3350 NF for oral solution are approximately $153 million.